Out-Licensing Opportunities
|
|
Many of our drug candidates are available for out-licensing in regions outside the U.S., such as Europe and Asia. The following is a list of our proprietary drugs available for co-development: |
In addition, Spectrum has a portfolio of neurology drug candidates that are available for out-licensing. For more information regarding these compounds and all our various out-licensing options, please contact us. |
This Web site contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and in reliance upon the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on the beliefs of the Company's management as well as assumptions made by and information currently available to the Company's management. Readers should not put undue reliance on these forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Spectrum Pharmaceuticals, Inc.'s actual results may differ materially from the results projected in the forward-looking statements. Factors that might cause such a difference include, but are not limited to, those discussed in the Company's most recent Form 10-K and 10-Qs. We do not plan to update any such forward-looking statements and expressly disclaim any duty to update the information contained in this filing except as required by law.
 |
All contents copyright Spectrum Pharmaceuticals, Inc. © 2012. All Rights Reserved. 1451-042001 |
Site Map | Privacy Policy | Terms of Use | Linking Policy Contact Us | Webmail |